NexCure
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- $19M
Investors
- 3
About NexCure
NexCure LLC, headquartered in Boston, US, specializes in enhancing accessibility to advanced cancer therapies by developing outpatient treatment centers focused on CAR-T and T-cell engager therapies. Founded in 2024 by President & CEO and co-founder Michael Richman, NexCure LLC operates outpatient treatment centers that provide advanced cancer therapies. The company has undergone significant operational strategies to address healthcare gaps, particularly in regions lacking specialized cancer treatment facilities.NexCure focuses on expanding access to advanced cancer therapies, primarily through the development and operation of outpatient treatment centers specializing in CAR-T and T-cell engager therapies. Their core offerings integrate a platform that utilizes AI-powered patient selection, remote monitoring, and standardized clinical protocols, ensuring that each patient receives personalized care. The company addresses critical gaps in the healthcare infrastructure, particularly where specialized cancer treatment centers are limited, and aims to improve treatment accessibility and outcomes by providing these services closer to patients' homes.NexCure's revenue structure is based on partnerships with health systems to create outpatient treatment centers that facilitate the administration of advanced cancer therapies. The company plans to expand its reach by establishing new outpatient centers in additional regions, enhancing access to its advanced cancer therapies across the United States.
Who invested in NexCure
3 investors across 1 round
See all investors in NexCure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 5, 2026
Amount
$19M
Investors
Questions about NexCure
Who invested in NexCure?
NexCure has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NexCure raised?
NexCure has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NexCure last raise money?
NexCure's most recent round on record is a Series A, in Mar 2026.
What does NexCure do?
NexCure LLC, headquartered in Boston, US, specializes in enhancing accessibility to advanced cancer therapies by developing outpatient treatment centers focused on CAR-T and T-cell engager therapies.
Where is NexCure headquartered?
NexCure is headquartered in Boston, US.
Which VCs invest in companies like NexCure?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at NexCure's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like NexCure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.